Proteo Inc (PTEO) Return on Equity ROE from the first quarter 2020 to first quarter 2019 and annually, average high and low, overall ranking from Mar 31 2020 to Mar 31 2019 - CSIMarket
CSIMarket
 


Proteo Inc  (PTEO)

Proteo Inc's ROE per quarter

Return on Equity, Quarterly Results, Trends, Rankings, Statistics


What is ROE for Proteo Inc in the first quarter 2020?
Due to the lack of equity, it was not possible to calculate Proteo Inc's return on equity (ROE) in its first quarter 2020

What is ROE?




Return On Equity (Mar 31 2020)
I. Quarter
(Dec 31 2019)
IV. Quarter
(Sep 30 2019)
III. Quarter
(Jun 30 2019)
II. Quarter
(Mar 31 2019)
I. Quarter
Y / Y Equity Change - - - - -
Y / Y Net Income Change - - - - -
Net Income (TTM) in Millions 0 0 0 0 0
Return On Equity (TTM) - - - - -
PTEO's Total Ranking # # # # #
Equity (TTM) in Millions 0 -1 -1 -1 -1
Seq. Equity Change - - - - -
Seq. Net Income Change - - - - -

Return On Equity Company Ranking
Within: No.
Industry #
Sector #
Overall #

Return On Equity Statistics
High Average Low
0 %
0 %
0 %
 





PTEO Annual Return On Equity (Dec 31 2019)
2019
(Dec 31 2018)
2018
(Dec 31 2017)
2017
(Dec 31 2016)
2016
(Dec 31 2015)
2015
Total Equity in Millions -1 -1 -1 -1 -1
Y / Y Equity Change - - - - -
Net Income in Millions 0 0 0 0 0
Y / Y Net Income Change - - - - -
Return On Equity - - - - -





More Return On Equity Ratios
Major Pharmaceutical Preparations Industry Roe Trends and Statistics
Healthcare Sector Return On Equity Statistics
PTEO's' Return on Equity at Yahoo Finance
PTEO's Roe Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and overall Market
Highest Ranking Return On Equity
Lowest Ranking Return On Equity
Subscribers only: Roe for PTEO's Competitors
Subscribers only: Roe for Proteo Inc's Suppliers
Subscribers only: Return On Equity for PTEO's Customers




Companies with similar Return On Equity at Mar 31 2020, within Healthcare Sector ROE
Molecular Templates Inc   103.65 %
Morphic Holding inc   93.74 %
Integrated Biopharma Inc  89.67 %
Black Diamond Therapeutics Inc   85.87 %
Amgen Inc   75.10 %
Jounce Therapeutics inc   74.73 %
Tenax Therapeutics Inc   73.78 %
Innoviva Inc   71.94 %
Zoetis Inc   61.08 %
Biolife Solutions Inc   55.64 %
Zynex inc   54.91 %
Catalyst Pharmaceuticals Inc   52.28 %
Vaso Corporation  51.35 %
Tenet Healthcare Corp  50.15 %
3m Company  48.47 %
Biogen Inc   44.47 %
Lifevantage Corp  41.31 %
Davita Inc   39.96 %
Palatin Technologies Inc   39.60 %
Alpha Pro Tech Ltd   39.03 %
Opiant Pharmaceuticals Inc   38.85 %
Merck and Co Inc   37.90 %
Boston Scientific Corporation  36.64 %
Hims and Hers Health Inc   35.55 %
Bionexus Gene Lab Corp   35.50 %
Chemed Corporation  34.23 %
Horizon Therapeutics Public Limited Company  31.80 %
Biomx Inc  31.24 %
Vanda Pharmaceuticals Inc   30.60 %
Corcept Therapeutics Inc  30.00 %


Date modified: 2026-09-18T13:11:04+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.